Gabapentin
Product Images NDC 10544-448

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 10544-448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Fig 1)

A line graph comparing mean pain scores over 8 weeks for two groups: placebo and Gabapentin 3600 mg/day. The x-axis represents weeks from baseline to week 8, and the y-axis shows mean pain scores from 0 to 10. A 4-week dose titration period and a 4-week fixed dose period are indicated at the top of the graph.*

FDA Label Image

Fig-2 (Fig 2)

Line graph showing mean pain scores over 7 weeks comparing placebo and gabapentin at dosages of 1800 mg/day and 2400 mg/day. The x-axis represents weeks including a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis represents mean pain scores from 0 to 10. Gabapentin groups show decreasing pain scores over time compared to placebo.*

FDA Label Image

Fig-3 (Fig 3)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It shows data from two studies comparing placebo (PBO) to Gabapentin (GBP) at different dosages (3600 mg in Study 1; 1800 mg and 2400 mg in Study 2). The chart displays percentages of responders for each group, with statistical significance markers (** p < 0.01, *** p < 0.001).*

FDA Label Image

Fig-4 (Fig 4)

A scatter plot comparing the percentage difference versus daily dose (mg) for Gabapentin across three studies labeled a, b, and c. The chart shows multiple data points for doses ranging from 600 mg to 1800 mg daily, marked with distinct symbols for each study group.*

FDA Label Image

Label 600mg 90ct (Label Gabapentin Tabs 600mg Bpi(10544 439 90) Glenmark(68462 126 05) Rev6)

Gabapentin Tablets, USP 600 mg in a package containing 90 tablets. The label indicates it is for Rx only, with storage instructions to keep at controlled room temperature 25°C (77°F) and excursions permitted between 15°-30°C (59°-86°F). The product is manufactured by Germany Pharmaceuticals Inc., USA, and labeled by Blenheim Pharmacal, Inc., New York, NY 12131. The label includes the NDC 10544-439-90 and the manufacturer code 68462-126-05.*

FDA Label Image

Label 800mg 90ct (Label Gabapentin Tabs 800mg Bpi(10544 448 90) Glenmark(68462 127 05) Rev2)

Gabapentin Tablets, USP 800mg label from Blenheim Pharmacal, Inc. The label indicates a package of 90 tablets with NDC 10544-448-90, includes storage instructions to keep at controlled room temperature, a barcode, and manufacturing details including lot number and expiration date placeholders. Directions to see the package insert for dosage are also noted.*

FDA Label Image

Equation 1 (Image 01)

A mathematical formula for calculating Creatinine Clearance (CLCr) involving age, weight, serum creatinine, and a factor for female patients. It shows the expression: [(140 minus age in years) times weight in kg] divided by (72 times serum creatinine in mg/dL), multiplied by 0.85 for female patients. No direct reference to Gabapentin or the labeler Blenheim Pharmacal, Inc. is visible.*

FDA Label Image

Glenmark Logo (Image 02)

FDA Label Image

Logo-1 (Logo 1)

FDA Label Image

Structure (Structure)

Chemical structure of gabapentin displaying a cyclohexane ring with attached amino (H2N) and carboxylic acid (COOH) groups. The structure illustrates the molecular framework of the active ingredient gabapentin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.